Why is Early Diagnosis Important?
[PreCISe]) in patients with isolated neurological episodes and MRI suggestive of MS have demonstrated the usefulness of immunomodulatory therapy in delaying the occurrence of a second relapse.
12- 15 As a result of the evidence from these studies, immunomodulatory therapy is now approved for use in MS from the very first relapse. All immunomodulatory drugs have demonstrated their usefulness compared with placebo in different stages of the disease, with the efficacy proving to be better the earlier therapy is
started. An early diagnosis of MS is therefore important for counselling individual patients and making decisions on the use of evidence-based disease-modifying treatments.
The Development of Criteria for the Diagnosis of Multiple Sclerosis
The diagnosis of MS is currently based on clinical parameters such as medical history and neurological examination, and paraclinical measures such as MRI, cerebrospinal fluid (CSF) examination and evoked potential testing.
Poser Diagnostic Criteria
Traditionally, diagnostic criteria for MS stated that a diagnosis of CDMS required clinical evidence of two or more lesions on at least two occasions. 16 In 1983, these criteria were expanded by Poser et al. to include the use of paraclinical parameters such as evoked potentials and CSF findings. 17 Poser et al. defined diagnostic categories and the highest degree of confidence was for CDMS, which was achieved when two relapses were identified, each confirmed by clinical examination, separated in space and time.
However, these criteria anteceded MRI and thus did not give specific recommendations on how to use this (now) important paraclinical tool.
The Impact of the Introduction of Magnetic Resonance Imaging
MRI has been shown to be the single most informative diagnostic procedure in recent years. Areas of abnormality on T2-weighted or proton-density-weighted images in a pattern highly characteristic for MS occur in more than 95% of patients with clinically definite disease and in 50-70% of patients with a CIS. MRI is also a powerful method for excluding other diseases that might simulate MS, which is a critical additional diagnostic step.
Based on developments on MRI techniques, in 1988 Paty et al. 18 proposed criteria for MS diagnosis that were supported by the presence of four or more lesions or three lesions, one of which needed to be periventricular. These criteria were prospectively evaluated in CIS patients and showed high sensitivity, but relatively low specificity, for the development of CDMS. Later, Fazekas et al. 19 proposed a modification of the MRI criteria. This consisted of the consideration of three or more lesions with at least two of the following characteristics:
• periventricular;
• infratentorial; and
• larger than 6mm.
These criteria showed both high sensitivity and specificity for MS diagnosis 20 when retrospectively evaluated in established MS and other disorders. However, when applied prospectively in CIS patients their performance was inferior in predicting conversion to CDMS.
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The Barkhof-Tintoré Criteria
In 1997 Barkhof et al. 22 proposed a model of four parameters that predicted conversion to CDMS better than previous or existing models. Those parameters were the presence of the following types of lesions:
• ≥1 gadolinium-enhancing;
• ≥1 juxtacortical;
• ≥1 infratentorial; and
• ≥3 periventricular.
The Barkhof criteria were further modified by Tintoré et al. 23 They allowed the gadolinium-enhancing lesion to be replaced by nine T2
lesions and introduced the concept of having at least three of the four Barkhof parameters. This enabled Tintoré et al. to achieve a higher accuracy and better balance between sensitivity and specificity for predicting CIS conversion to CDMS.
The McDonald Criteria
In For DIS, the role of spinal cord lesions has been redefined:
Early Identification of Clinically Isolated Syndrome
• a cord lesion is equivalent to, and can be a substitute for, a brain infratentorial lesion, but not for a periventricular or juxtacortical lesion;
• an enhancing cord lesion can doubly fulfill the criteria; and The new criteria were designed in order to simplify and reduce the number of lesions and regions needed for radiological DIS to a minimum (≥1 lesions in ≥2 of the four regions).
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Although the delay required for a second MRI scan may prevent incorrect and premature diagnosis, there is evidence that the presence of non-enhancing and enhancing lesions on a single MRI, even if obtained within the first three months after the first symptom, could be sufficient to establish DIT. This is because it is likely that this combination reflects lesions in different stages of evolution. has proposed new algorithms for MS diagnosis (see Table 2 and . 29 DIT criteria can be fulfilled by:
• the presence of one or more asymptomatic gadolinium-enhancing and non-enhancing lesions, irrespective of the time of the scan; or
• the presence of a new T2 and/or gadolinium-enhancing lesion compared to a previous scan, irrespective of the time of the reference scan.
Implications of the New Criteria
MRI is not only a diagnostic tool but also prognostic tool, as it can predict conversion to CDMS. Therefore 
